New injection could ease severe cancer bone pain
NCT ID NCT02522611
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 3 times
Summary
This early-stage trial tests a drug called resiniferatoxin (RTX) for people with severe bone pain from cancer that hasn't been helped by standard treatments. About 30 adults will receive a single injection into the spine to see if it safely reduces pain. The study will track pain levels and side effects for up to 6 months after the injection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACTABLE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Training healthcare teams to see the whole person behind the illness
- A 6-week coaching program may lift the weight on family caregivers — a study asks if it works.
- Can a simple text message transform cancer care?
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Mushroom extract put to the test for advanced cancer Well-Being
- A simple lesson before discharge could ease the heavy load on family caregivers